Albert H. Meier
46Patents
31h-index
3Co-inventors
78Inventor score
Filing activity: Jan 3, 1980 → Jan 13, 2000
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5714519A | Method for regulating glucose metabolism | Human Necessities | 76 | Expired |
| US5344832A | Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates | Human Necessities | 63 | Expired |
| US5006526A | Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis | Human Necessities | 62 | Expired |
| US4659715A | Method of inhibiting body fat stores | Human Necessities | 62 | Expired |
| US4783469A | Method of inhibiting body fat stores | Human Necessities | 61 | Expired |
| US5468755A | Therapeutic process for the treatment of the pathologies of Type II diabetes | Human Necessities | 59 | Expired |
| US5866584A | Therapeutic process for the treatment of the pathologies of type II diabetes | Physics | 57 | Expired |
| US5668155A | Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders | Physics | 56 | Expired |
| US4749709A | Method of inhibiting body fat stores | Human Necessities | 46 | Expired |
| US5496803A | Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia in vertebrates | Physics | 44 | Expired |
| US5585347A | Methods for the determination and adjustment of prolactin daily rhythms | Emerging Cross-Sectional Technologies | 43 | Expired |
| US5872127A | Method of regulating immune function | Human Necessities | 41 | Expired |
| US5626860A | Method for regulating metabolism with dopamine beta hydroxylase inhibitors | Human Necessities | 41 | Expired |
| US5554623A | Method for the long term reduction of body fat stores, insulin resistance, hypersinsulinemia and hyperglycemia in vertebrates | Human Necessities | 40 | Expired |
| US5905083A | Method of treating rheumatoid arthritis | Human Necessities | 38 | Expired |
| US5696128A | Method of regulating immune function | Human Necessities | 36 | Expired |
| US5760047A | Method for treatment of obesity using prolactin modulators and diet | Physics | 35 | Expired |
| US5741503A | Method for regulating metabolism with dopamine beta hydroxylase inhibitors | Human Necessities | 35 | Expired |
| US5756513A | Therapeutic process for the treatment of the pathologies of type II diabetes | Human Necessities | 34 | Expired |
| US6071914A | Method for inhibiting neoplastic disease in mammals | Human Necessities | 34 | Expired |
| US5830895A | Methods for the determination and adjustment of prolactin daily rhythms | Emerging Cross-Sectional Technologies | 34 | Expired |
| US5716957A | Method for modifying and resetting the bloodstream prolactin levels of a human subject | Human Necessities | 33 | Expired |
| US5744477A | Method for treatment of obesity using prolactin modulators and diet | Physics | 33 | Expired |
| US5712265A | Administration of pirenzepine, methyl scopolamine and other muscarinin receptor antagonists for treatment of glucose metabolism disorders | Physics | 33 | Expired |
| US6075020A | Method of regulating immune function | Human Necessities | 33 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.